{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:06:00Z","timestamp":1789682760014,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2019-1482"],"award-info":[{"award-number":["2019-1482"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2019-1482"],"award-info":[{"award-number":["2019-1482"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2019-1482"],"award-info":[{"award-number":["2019-1482"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2019-1482"],"award-info":[{"award-number":["2019-1482"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2019-1482"],"award-info":[{"award-number":["2019-1482"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Proteasome inhibitors (PIs) represent the gold standard in the treatment of multiple myeloma. Among PIs, Bortezomib (BTZ) is frequently used as first line therapy, but peripheral neuropathy (PN), occurring approximately in 50% of patients, impairs their life, representing a dose-limiting toxicity. Carfilzomib (CFZ), a second-generation PI, induces a significantly less severe PN. We investigated possible BTZ and CFZ off-targets able to explain their different neurotoxicity profiles. In order to identify the possible PIs off-targets we used the SPILLO-PBSS software that performs a structure-based in silico screening on a proteome-wide scale. Among the top-ranked off-targets of BTZ identified by SPILLO-PBSS we focused on tubulin which, by contrast, did not turn out to be an off-target of CFZ. We tested the hypothesis that the direct interaction between BTZ and microtubules would inhibit the tubulin alfa GTPase activity, thus reducing the microtubule catastrophe and consequently furthering the microtubules polymerization. This hypothesis was validated in a cell-free model, since BTZ (but not CFZ) reduces the concentration of the free phosphate released during GTP hydrolysis. Moreover, NMR binding studies clearly demonstrated that BTZ, unlike CFZ, is able to interact with both tubulin dimers and polymerized form. Our data suggest that different BTZ and CFZ neurotoxicity profiles are independent from their proteasome inhibition, as demonstrated in adult mice dorsal root ganglia primary sensory neurons, and, first, we demonstrate, in a cell free model, that BTZ is able to directly bind and perturb microtubules.<\/jats:p>","DOI":"10.1038\/s41598-021-89856-3","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T10:06:23Z","timestamp":1621332383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect"],"prefix":"10.1038","volume":"11","author":[{"given":"A.","family":"Malacrida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Semperboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Di Domizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Palmioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Broggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Airoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Meregalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cavaletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nicolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"89856_CR1","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1158\/1078-0432.CCR-10-1950","volume":"17","author":"S Arastu-Kapur","year":"2011","unstructured":"Arastu-Kapur, S. et al. Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: A link to clinical adverse events. Clin. Cancer Res. 17, 2734\u20132743. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1950 (2011).","journal-title":"Clin. Cancer Res."},{"key":"89856_CR2","doi-asserted-by":"publisher","first-page":"16318","DOI":"10.1038\/s41598-018-34507-3","volume":"8","author":"B Karademir","year":"2018","unstructured":"Karademir, B. et al. Proteomic approach for understanding milder neurotoxicity of Carfilzomib against Bortezomib. Sci. Rep. 8, 16318. https:\/\/doi.org\/10.1038\/s41598-018-34507-3 (2018).","journal-title":"Sci. Rep."},{"key":"89856_CR3","doi-asserted-by":"publisher","first-page":"101502","DOI":"10.1016\/j.redox.2020.101502","volume":"32","author":"AT Jannuzzi","year":"2020","unstructured":"Jannuzzi, A. T. et al. Higher proteotoxic stress rather than mitochondrial damage is involved in higher neurotoxicity of bortezomib compared to carfilzomib. Redox Biol. 32, 101502. https:\/\/doi.org\/10.1016\/j.redox.2020.101502 (2020).","journal-title":"Redox Biol."},{"key":"89856_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14740338.2017.1259310","volume":"16","author":"D Schlafer","year":"2017","unstructured":"Schlafer, D., Shah, K. S., Panjic, E. H. & Lonial, S. Safety of proteasome inhibitors for treatment of multiple myeloma. Expert Opin. Drug Saf. 16, 167\u2013183. https:\/\/doi.org\/10.1080\/14740338.2017.1259310 (2017).","journal-title":"Expert Opin. Drug Saf."},{"key":"89856_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neulet.2014.10.014","volume":"596","author":"VA Carozzi","year":"2015","unstructured":"Carozzi, V. A., Canta, A. & Chiorazzi, A. Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?. Neurosci. Lett. 596, 90\u2013107. https:\/\/doi.org\/10.1016\/j.neulet.2014.10.014 (2015).","journal-title":"Neurosci. Lett."},{"key":"89856_CR6","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3390\/ijms20092287","volume":"20","author":"A Malacrida","year":"2019","unstructured":"Malacrida, A., Meregalli, C., Rodriguez-Menendez, V. & Nicolini, G. Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton. Int. J. Mol. Sci. 20, 2287. https:\/\/doi.org\/10.3390\/ijms20092287 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"89856_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.4161\/cc.27476","volume":"13","author":"C Meregalli","year":"2014","unstructured":"Meregalli, C. et al. Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy. Cell Cycle 13, 612\u2013621. https:\/\/doi.org\/10.4161\/cc.27476 (2014).","journal-title":"Cell Cycle"},{"key":"89856_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.conb.2019.01.003","volume":"57","author":"MT Kelliher","year":"2019","unstructured":"Kelliher, M. T., Saunders, H. A. & Wildonger, J. Microtubule control of functional architecture in neurons. Curr. Opin. Neurobiol. 57, 39\u201345. https:\/\/doi.org\/10.1016\/j.conb.2019.01.003 (2019).","journal-title":"Curr. Opin. Neurobiol."},{"key":"89856_CR9","doi-asserted-by":"publisher","first-page":"e2012685118","DOI":"10.1073\/pnas.2012685118","volume":"118","author":"ME Pero","year":"2021","unstructured":"Pero, M. E. et al. Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy. Proc. Natl. Acad. Sci. USA 118, e2012685118. https:\/\/doi.org\/10.1073\/pnas.2012685118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"89856_CR10","unstructured":"RCSB Protein Data Bank http:\/\/www.rcsb.org\/."},{"key":"89856_CR11","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/jcc.23714","volume":"35","author":"A Di Domizio","year":"2014","unstructured":"Di Domizio, A., Vitriolo, A., Vistoli, G. & Pedretti, A. SPILLO-PBSS: Detecting hidden binding sites within protein 3D-structures through a flexible structure-based approach. J. Comput. Chem. 35, 2005\u20132017. https:\/\/doi.org\/10.1002\/jcc.23714 (2014).","journal-title":"J. Comput. Chem."},{"key":"89856_CR12","doi-asserted-by":"publisher","first-page":"115300","DOI":"10.1016\/j.bmc.2019.115300","volume":"28","author":"A Malacrida","year":"2020","unstructured":"Malacrida, A. et al. 3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line. Bioorg. Med. Chem. 28, 115300. https:\/\/doi.org\/10.1016\/j.bmc.2019.115300 (2020).","journal-title":"Bioorg. Med. Chem."},{"key":"89856_CR13","unstructured":"SPILLOproject https:\/\/www.spilloproject.com."},{"key":"89856_CR14","unstructured":"ACD\/ChemSketch, version 2020.2.0, Advanced Chemistry Development, Inc., Toronto, ON, Canada. http:\/\/www.acdlabs.com (2021)."},{"key":"89856_CR15","unstructured":"Williams T., Kelley C., et al. Gnuplot 5.2 http:\/\/www.gnuplot.info (2019)."},{"key":"89856_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clbc.2011.03.006","volume":"11","author":"K Carlson","year":"2011","unstructured":"Carlson, K. & Ocean, A. J. Peripheral neuropathy with microtubule-targeting agents: Occurrence and management approach. Clin. Breast Cancer 11, 73\u201381. https:\/\/doi.org\/10.1016\/j.clbc.2011.03.006 (2011).","journal-title":"Clin. Breast Cancer"},{"key":"89856_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jmb.2011.07.029","volume":"412","author":"A Nawrotek","year":"2011","unstructured":"Nawrotek, A., Knossow, M. & Gigant, B. The determinants that govern microtubule assembly from the atomic structure of GTP-tubulin. J. Mol. Biol. 412, 35\u201342. https:\/\/doi.org\/10.1016\/j.jmb.2011.07.029 (2011).","journal-title":"J. Mol. Biol."},{"key":"89856_CR18","unstructured":"BLAST http:\/\/www.uniprot.org\/blast\/."},{"key":"89856_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fpls.2014.00511","volume":"5","author":"T Horio","year":"2014","unstructured":"Horio, T. & Murata, T. The role of dynamic instability in microtubule organization. Front. Plant Sci. 5, 511. https:\/\/doi.org\/10.3389\/fpls.2014.00511 (2014).","journal-title":"Front. Plant Sci."},{"key":"89856_CR20","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1021\/bi982461r","volume":"38","author":"G Chakrabarti","year":"1999","unstructured":"Chakrabarti, G., Kim, S., Gupta, M. L., Barton, J. S. & Himes, R. H. Stabilization of tubulin by deuterium oxide. Biochemistry 38, 3067\u20133072. https:\/\/doi.org\/10.1021\/bi982461r (1999).","journal-title":"Biochemistry"},{"key":"89856_CR21","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q","volume":"38","author":"M Mayer","year":"1999","unstructured":"Mayer, M. & Meyer, B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. Engl. 38, 1784\u20131788. https:\/\/doi.org\/10.1002\/(SICI)1521-3773(19990614)38:12%3c1784::AID-ANIE1784%3e3.0.CO;2-Q (1999).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"89856_CR22","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.1016\/S0021-9258(17)40053-6","volume":"252","author":"RH Himes","year":"1977","unstructured":"Himes, R. H., Burton, P. R. & Gaito, J. M. Dimethyl sulfoxide-induced self-assembly of tubulin lacking associated proteins. J. Biol. Chem. 252, 6222\u20136228 (1977).","journal-title":"J. Biol. Chem."},{"key":"89856_CR23","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1016\/S0021-9258(19)83785-7","volume":"257","author":"J Robinson","year":"1982","unstructured":"Robinson, J. & Engelborghs, Y. Tubulin polymerization in dimethyl sulfoxide. J. Biol. Chem. 257, 5367\u20135371 (1982).","journal-title":"J. Biol. Chem."},{"key":"89856_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2016.12.007","volume":"103","author":"GS Kaplan","year":"2017","unstructured":"Kaplan, G. S., Torcun, C. C., Grune, T., Ozer, N. K. & Karademir, B. Proteasome inhibitors in cancer therapy: Treatment regimen and peripheral neuropathy as a side effect. Free Radic. Biol. Med. 103, 1\u201313. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.12.007 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"89856_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.neuron.2015.05.046","volume":"87","author":"LC Kapitein","year":"2015","unstructured":"Kapitein, L. C. & Hoogenraad, C. C. Building the neuronal microtubule cytoskeleton. Neuron 87, 492\u2013506. https:\/\/doi.org\/10.1016\/j.neuron.2015.05.046 (2015).","journal-title":"Neuron"},{"key":"89856_CR26","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.cub.2007.08.063","volume":"17","author":"C Elie-Caille","year":"2007","unstructured":"Elie-Caille, C. et al. Straight GDP-tubulin protofilaments form in the presence of taxol. Curr. Biol. 17, 1765\u20131770. https:\/\/doi.org\/10.1016\/j.cub.2007.08.063 (2007).","journal-title":"Curr. Biol."},{"key":"89856_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/med.20242","volume":"31","author":"RA Stanton","year":"2011","unstructured":"Stanton, R. A., Gernert, K. M., Nettles, J. H. & Aneja, R. Drugs that target dynamic microtubules: A new molecular perspective. Med. Res. Rev. 31, 443\u2013481. https:\/\/doi.org\/10.1002\/med.20242 (2011).","journal-title":"Med. Res. Rev."},{"key":"89856_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neuro.2013.09.001","volume":"39","author":"NP Staff","year":"2013","unstructured":"Staff, N. P. et al. Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons. Neurotoxicology 39, 124\u2013131. https:\/\/doi.org\/10.1016\/j.neuro.2013.09.001 (2013).","journal-title":"Neurotoxicology"},{"key":"89856_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0006-8993(95)00100-5","volume":"676","author":"JW Russell","year":"1995","unstructured":"Russell, J. W., Windebank, A. J., McNiven, M. A., Brat, D. J. & Brimijoin, W. S. Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity. Brain Res. 676, 258\u2013267. https:\/\/doi.org\/10.1016\/0006-8993(95)00100-5 (1995).","journal-title":"Brain Res."},{"key":"89856_CR30","doi-asserted-by":"publisher","first-page":"e45776","DOI":"10.1371\/journal.pone.0045776","volume":"7","author":"D Schellingerhout","year":"2012","unstructured":"Schellingerhout, D., LeRoux, L. G., Hobbs, B. P. & Bredow, S. Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging. PLoS ONE 7, e45776. https:\/\/doi.org\/10.1371\/journal.pone.0045776 (2012).","journal-title":"PLoS ONE"},{"key":"89856_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s12640-017-9760-7","volume":"32","author":"I Bobylev","year":"2017","unstructured":"Bobylev, I. et al. Kinesin-5 blocker monastrol protects against bortezomib-induced peripheral neurotoxicity. Neurotox. Res. 32, 555\u2013562. https:\/\/doi.org\/10.1007\/s12640-017-9760-7 (2017).","journal-title":"Neurotox. Res."},{"key":"89856_CR32","doi-asserted-by":"publisher","first-page":"940","DOI":"10.4161\/cc.7.7.5625","volume":"7","author":"MS Poruchynsky","year":"2008","unstructured":"Poruchynsky, M. S. et al. Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: A possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition. Cell Cycle 7, 940\u2013949. https:\/\/doi.org\/10.4161\/cc.7.7.5625 (2008).","journal-title":"Cell Cycle"},{"key":"89856_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1083\/jcb.201407095","volume":"207","author":"GJ Brouhard","year":"2014","unstructured":"Brouhard, G. J. & Rice, L. M. The contribution of \u03b1\u03b2-tubulin curvature to microtubule dynamics. J. Cell Biol. 207, 323\u2013334. https:\/\/doi.org\/10.1083\/jcb.201407095 (2014).","journal-title":"J. Cell Biol."},{"key":"89856_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1083\/jcb.201104034","volume":"194","author":"T Nakata","year":"2011","unstructured":"Nakata, T., Niwa, S., Okada, Y., Perez, F. & Hirokawa, N. Preferential binding of a kinesin-1 motor to GTP-tubulin-rich microtubules underlies polarized vesicle transport. J. Cell Biol. 194, 245\u2013255. https:\/\/doi.org\/10.1083\/jcb.201104034 (2011).","journal-title":"J. Cell Biol."},{"key":"89856_CR35","doi-asserted-by":"publisher","first-page":"e202007033","DOI":"10.1083\/jcb.202007033","volume":"220","author":"R Ayukawa","year":"2021","unstructured":"Ayukawa, R. et al. GTP-dependent formation of straight tubulin oligomers leads to microtubule nucleation. J. Cell Biol. 220, e202007033. https:\/\/doi.org\/10.1083\/jcb.202007033 (2021).","journal-title":"J. Cell Biol."},{"key":"89856_CR36","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/ejoc.200600132","volume":"3707\u20133720","author":"F Peri","year":"2006","unstructured":"Peri, F. et al. Sugar-derived Ras inhibitors: Group epitope mapping by NMR spectroscopy and biological evaluation. Eur. J. Org. Chem. 3707\u20133720, 2006. https:\/\/doi.org\/10.1002\/ejoc.200600132 (2006).","journal-title":"Eur. J. Org. Chem."},{"key":"89856_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/9781608059652115020006","volume-title":"Applications of NMR Spectroscopy","author":"C Airoldi","year":"2015","unstructured":"Airoldi, C., Merlo, S. & Sironi, E. Applications of NMR Spectroscopy 147\u2013219 (Bentham & Science Publishers Ltd, 2015)."},{"key":"89856_CR38","doi-asserted-by":"publisher","first-page":"18383","DOI":"10.1002\/chem.201503086","volume":"21","author":"M Bonanomi","year":"2015","unstructured":"Bonanomi, M. et al. How epigallocatechin-3-gallate and tetracycline interact with the Josephin domain of ataxin-3 and alter its aggregation mode. Chemistry 21, 18383\u201318393. https:\/\/doi.org\/10.1002\/chem.201503086 (2015).","journal-title":"Chemistry"},{"key":"89856_CR39","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1002\/cbic.201900383","volume":"20","author":"A Palmioli","year":"2019","unstructured":"Palmioli, A., Sperandeo, P., Polissi, A. & Airoldi, C. Targeting bacterial biofilm: A new LecA multivalent ligand with inhibitory activity. ChemBioChem 20, 2911\u20132915. https:\/\/doi.org\/10.1002\/cbic.201900383 (2019).","journal-title":"ChemBioChem"},{"key":"89856_CR40","unstructured":"MakeMultimer http:\/\/watcut.uwaterloo.ca\/tools\/makemultimer\/index."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89856-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89856-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89856-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T08:16:14Z","timestamp":1670055374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89856-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["89856"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-89856-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"20 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10523"}}